CBG, CBC, CBN, and CBDV have shown promise as anti-cancer agents in the treatment of blood cancer.
The first patient to receive medical cannabis flower through the NHS has shared how it helped him manage debilitating side-effects of cancer treatment.
A daily dose of more than 4.7mg ‘significantly prolonged' survival time and also improved quality of life.
A cannabis extract has shown positive results in slowing down melanoma cell growth.
The findings could pave the way for new treatments for appetite disorders experienced by cancer patients, anorexia and obesity.
A cannabis charity raised over €400,000 to make the trial possible.
Catch up on some of the latest cannabis science.
The findings of the review will inform a future RCT looking at the tolerability of cannabinoids in children with cancer.
Oxford Cannabinoid Technologies is expanding its research and development into oncology.
Catch up on some of the latest cannabis science